NCT07034924 Temporary Aortic Compression With the Abdominal Tourniquet for Refractory Postpartum Hemorrhage
| NCT ID | NCT07034924 |
| Status | Recruiting |
| Phase | — |
| Sponsor | LLC UkrMedGroup |
| Condition | Postpartum Hemorrhage |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-07-01 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2025-07-01 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This multicenter study aims to evaluate effectiveness and safety of using the AAJT-S device as a temporary intervention for severe, atony-related PPH that is refractory to standard therapies
Eligibility Criteria
Inclusion Criteria: * Age ≥18 years * Clinical diagnosis of postpartum hemorrhage (PPH) refractory to uterotonics and intrauterine balloon tamponade * Estimated blood loss greater than 1300 mL * Oral informed consent provided prior to device application Exclusion Criteria: * Patients with postpartum bleeding as a result of trauma, retained placenta or coagulopathy were excluded
Frequently Asked Questions
Who can join the NCT07034924 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 50 Years, studying Postpartum Hemorrhage. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07034924 currently recruiting?
Yes, NCT07034924 is actively recruiting participants. Visit ClinicalTrials.gov or contact LLC UkrMedGroup to inquire about joining.
Where is the NCT07034924 trial being conducted?
This trial is being conducted at Zaporizhzhia, Ukraine.
Who is sponsoring the NCT07034924 clinical trial?
NCT07034924 is sponsored by LLC UkrMedGroup. The trial plans to enroll 20 participants.